Oscar Health, Inc.
OSCR · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,835 | $5,433 | $3,294 | $3,231 |
| - Cash | $2,149 | $2,599 | $2,237 | $1,527 |
| + Debt | $686 | $300 | $300 | $300 |
| Enterprise Value | $3,373 | $3,134 | $1,357 | $2,003 |
| Revenue | $2,986 | $2,864 | $3,046 | $2,393 |
| % Growth | 4.3% | -6% | 27.3% | – |
| Gross Profit | $2,986 | $2,864 | $3,046 | $2,393 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$125 | -$221 | $301 | -$138 |
| % Margin | -4.2% | -7.7% | 9.9% | -5.8% |
| Net Income | -$137 | -$228 | $275 | -$154 |
| % Margin | -4.6% | -8% | 9% | -6.4% |
| EPS Diluted | -0.53 | -0.89 | 0.92 | -0.62 |
| % Growth | 40.4% | -196.7% | 248.4% | – |
| Operating Cash Flow | -$965 | $509 | $879 | $347 |
| Capital Expenditures | -$9 | -$9 | -$9 | -$7 |
| Free Cash Flow | -$974 | $500 | $870 | $340 |